Skip to content

Ramin Ebrahimi, MD

NPI 1992816631ActiveIndividual· Nuclear Medicine, Nuclear Cardiology· Los Angeles, CA

Nuclear Medicine, Nuclear Cardiology (MD) in Los Angeles, California, licensed in CA, with an NPI issued in August 2006. Part D covered 38 prescriptions written in 2024. Novo Nordisk Inc was the largest of 2 companies reporting payments in 2025, $74,588 in all, mostly speaking and faculty fees.

Overview

NPI1992816631
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 31, 2006
Last updated in NPPESSep 11, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)38 · 44 30-day fills
Total drug cost$17,600

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$74,588 · 32 payments from 2 companies
  • 2024$67,431 · 38 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$74,55531
Shockwave Medical, Inc$33.471

What the 2025 payments were for

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$67,147 · 13 payments
  • Travel and Lodging$6,736 · 12 payments
  • Food and Beverage$705.20 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine, Nuclear Cardiology providers in Los Angeles

All Nuclear Medicine, Nuclear Cardiology providers in California →